From August 15 to 17, 2024, the 2024 Diabetes Education and Management Academic Conference, hosted by the Chinese Association for Health Promotion and Education, was held in Hefei, Anhui Province. With the theme 「Innovative Practices in DSMES and Tiered Management」, the conference focused on new technologies and models in diabetes education and management, aiming to explore the cutting-edge developments in the field.

In the exhibition area, TUL showcased its core insulin product portfolio, including human insulin injection, insulin glargine injection, and insulin aspart injection. The company shared its strategic blueprint for the future development of antidiabetic biologics with many experts and scholars, demonstrating its long-term layout for diabetes treatment.